Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Posted on 25/02/202525/02/2025 by Book of Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

Publications

📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025

📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025

📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024

📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024

Pawan Gupta | Health Professions | Best Researcher Award

Posted on 20/12/202420/12/2024 by Book of Award

Dr. Pawan Gupta | Health Professions | Best Researcher Award

Innovative Cancer Care and Rehabilitation Pvt. Ltd | India

Author Profile

Scopus

Orcid

🌟 Early Academic Pursuits

Dr. Pawan Gupta’s academic journey reflects his passion for excellence in oncology and surgical practice. He graduated with an MBBS degree in 1991 from SCB Medical College, Cuttack, followed by an MS in General Surgery in 1996. In 2001, he completed his M.Ch. in Onco-Surgery at Gujarat University, further enhancing his skills with training at the Tata Memorial Hospital in Mumbai. His international exposure includes earning the FRCS I from the Royal College of Surgeons, Glasgow, and advanced training in voice rehabilitation and photodynamic therapy. These formative years laid the foundation for his groundbreaking career in cancer care.

🏥 Professional Endeavors

As the Senior Director of Head and Neck Cancer Surgery at MAX Institute of Cancer Care, Dr. Gupta has made significant strides in oncology. He is the visionary founder of ICanCaRe, a pioneering platform dedicated to cancer care and tobacco deaddiction. Through innovative tools like the ICanCaRe App, Virtual Clinics, and the National Quitline, his work has revolutionized patient rehabilitation. Additionally, his leadership roles include serving as National President and Senior Vice Chairman of the I CAN WIN Foundation, where he champions cancer prevention and treatment initiatives.

📚 Contributions and Research Focus

Dr. Gupta’s research and contributions are pivotal in advancing cancer care. With over 30 publications in esteemed journals and authorship of six influential books, he has enriched both the academic and practical fields of oncology. His patented instrument, TrisCaRe, demonstrates his commitment to innovation, addressing specific challenges in oral cancer treatment. As a master trainer for tobacco cessation under Gujarat University, Dr. Gupta has trained more than 1,000 specialists, cementing his role in global health initiatives.

🏅 Accolades and Recognition

Dr. Gupta’s impactful work has earned him numerous prestigious awards, including the ICD International Award (2007), the Vivekananda Sister Margarette Award (2017), and the Inspiring Oncologist 2024 Award by Times Network. These accolades honor his relentless dedication to cancer care, tobacco cessation, and public health advocacy.

🌍 Impact and Influence

Dr. Gupta’s influence extends far beyond clinical practice. His motivational talk, "Making of Cancer Winners," delivered at the Livestrong Global Summit in Dublin, inspired a global audience. His campaigns, such as "Win Over Cancer" and "Save the Youth – Win Over Tobacco," have garnered widespread recognition, transforming public attitudes toward cancer prevention and tobacco deaddiction.

🌱 Legacy and Future Contributions

Dr. Gupta’s holistic approach to oncology and his visionary projects, such as ICanCaRe, ensure his lasting legacy in the fight against cancer. As he continues to innovate and inspire, his work paves the way for a healthier, cancer-free future. His dedication to research, public education, and compassionate care underscores a career marked by transformative achievements and unwavering commitment to humanity.

Publications

📝 Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs
Authors: Kannan, S., Gokul Krishna, S., Gupta, P.K., Kolkundkar, U.K.
Journal: Scientific Reports
Year: 2024

📝 Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease
Authors: Gupta, P.K., Shivashankar, P., Rajkumar, M., Manjuprasad, M.S., Udaykumar, K.
Journal: Stem Cell Research and Therapy
Year: 2023

📝 Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
Authors: Gupta, P.K., Maheshwari, S., Cherian, J.J., Verma, N.N., Kumar, U.
Journal: American Journal of Sports Medicine
Year: 2023

📝 Comparison of guidelines for biological ancillary materials used for the manufacture of gene and cellular therapy products in Asia
Authors: Tanaka, T., Yoshimura, K., Chang, R., Zhao, X., Takakura, K.
Journal: Cytotherapy
Year: 2023

Livia Augustin | Medicine and Dentistry | Best Researcher Award

Posted on 05/08/202405/08/2024 by Book of Award

Dr. Livia Augustin | Medicine and Dentistry | Best Researcher Award

National Cancer Institute Pascale Napoli | Italy

Author Profile

Scopus

Early Academic Pursuits 🎓

Dr. Livia Augustin embarked on her academic journey with a Bachelor of Science in Nutritional Sciences and Human Biology from the University of Toronto in 1995, complemented by a minor in Psychology. Her passion for understanding the interplay between diet and health led her to pursue a Master of Science in Nutritional Sciences at the same institution, where she investigated the effects of wheat bran on serum lipids and colonic health. Dr. Augustin's quest for deeper knowledge culminated in a Doctor of Philosophy in Human Health and Nutritional Sciences from the University of Guelph in 2010. Her thesis explored the dietary glycemic index's implications on cancer risk, growth factors, and oxidative stress, marking a significant contribution to nutritional science.

Professional Endeavors 🌟

Dr. Augustin's professional career has been distinguished by her roles as a Nutrition Researcher and Study Coordinator at the National Cancer Institute Fondazione G. Pascale in Naples, Italy, since 2015. Her work has spanned across various esteemed institutions, including the Centro Riferimento Oncologico, Clinical Nutrition and Risk Factor Modification Centre at St. Michael’s Hospital, and the University of Milan. Her international collaborations extend to King's College London, Brighton University, and the Hellenic Health Foundation. Previously, she has worked at Unilever R&D, the Clinical Nutrition and Risk Factor Modification Centre, and as a Research Assistant at the Department of Epidemiology and the University of Toronto.

Contributions and Research Focus 🔬

Dr. Augustin's research has significantly advanced the understanding of lifestyle factors and their impact on cancer. Her notable studies include evaluating the long-term effects of integrated lifestyle treatments on breast cancer survivors and examining the influence of diet, exercise, and vitamin D supplementation on breast cancer recurrence. Her research has explored dietary habits, physical activity, and psychological states in breast cancer survivors, contributing valuable insights into improving quality of life and health outcomes in this population.

Accolades and Recognition 🏆

Dr. Augustin's contributions to nutritional science and cancer research have been recognized through several substantial grants. She has led projects funded by the Italian Ministry of Health and various Italian cancer research organizations, including LILT and the Lega Italiana per la Lotta contro i Tumori. Her grants support significant research into dietary interventions, cancer prevention, and quality of life improvements for cancer patients.

Impact and Influence 🌍

Dr. Augustin's work has had a profound impact on the field of nutrition and cancer research, influencing dietary recommendations and lifestyle interventions aimed at reducing cancer risk and improving patient outcomes. Her leadership in organizing scientific events and her role as a university speaker have further cemented her position as a leading figure in her field.

Legacy and Future Contributions 🌱

Looking ahead, Dr. Augustin continues to shape the future of nutritional science through her innovative research and commitment to improving cancer care. Her ongoing projects and collaborations promise to further advance our understanding of diet and lifestyle's role in health and disease. Her dedication to research supervision and student training also ensures that the next generation of scientists will benefit from her expertise and passion.

Publications 📘

📄Baseline Association between Healthy Eating Index-2015 and Health-Related Quality of Life in Breast Cancer Patients Enrolled in a Randomized Trial
Authors: Porciello, G., Coluccia, S., Vitale, S., Celentano, E., Augustin, L.S.A.
Journal: Cancers
Year: 2024

📄Diabetes Risk Reduction Diet and Colorectal Cancer Risk
Authors: Natale, A., Turati, F., Taborelli, M., Rossi, M., Vecchia, C.L.
Journal: Cancer Epidemiology Biomarkers and Prevention
Year: 2024

📄Central Obesity, Body Mass Index, Metabolic Syndrome and Mortality in Mediterranean Breast Cancer Patients
Authors: Crispo, A., Augustin, L.S.A., Luongo, A., La Vecchia, C., Arpino, G.
Journal: Scientific Reports
Year: 2023

📄Diabetes Risk Reduction Diet and Ovarian Cancer Risk: An Italian Case-Control Study
Authors: Esposito, G., Turati, F., Parazzini, F., Negri, E., La Vecchia, C.
Journal: Cancer Causes and Control
Year: 2023

📄One-Year Nutrition Counselling in the Context of a Mediterranean Diet Reduced the Dietary Inflammatory Index in Women with Breast Cancer: A Role for the Dietary Glycemic Index
Authors: Vitale, S., Palumbo, E., Polesel, J., Jenkins, D.J.A., Augustin, L.S.A.
Journal: Food and Function
Year: 2023

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on 23/04/202423/04/2024 by Book of Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa's academic journey commenced with a Bachelor's in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He pursued his passion further with a Master's in Biosciences from COMSATS University Islamabad, Pakistan, where he delved into cancer genetics. Currently, he is pursuing a Ph.D. in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDs, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

Jairus has garnered diverse professional experiences, from his tenure as a Laboratory Analyst at the Regional Veterinary Investigation Laboratory, Kenya, to his role as the Head of Public Needs Research at the Integrated Cancer Research Foundation of Kenya. He has contributed significantly to cancer education and research, both as a volunteer and in leadership positions, demonstrating his commitment to advancing cancer management in Kenya.

Contributions and Research Focus

With a strong background in biochemistry, genetics, and molecular biology, Jairus has dedicated his research efforts to elucidating the roles of non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker discovery, and DNA repair mechanisms. His research spans both experimental and computational domains, aiming to unravel the complexities of cancer genetics and improve therapeutic strategies.

Accolades and Recognition

Jairus's contributions to the field of cancer genetics have been recognized internationally. He has been awarded prestigious scholarships, including the Queen Elizabeth Commonwealth Scholarship, and has received honors for his academic achievements. Additionally, his research publications in reputable journals underscore his growing influence in the scientific community.

Impact and Influence

Through his research, leadership roles, and volunteer activities, Jairus has made a significant impact on cancer education, awareness, and research in Kenya. His work has contributed to the understanding of cancer pathogenesis and has paved the way for innovative approaches to cancer management and treatment.

Legacy and Future Contributions

As Jairus continues his doctoral studies and pursues his research interests in cancer genetics, he aims to leave a lasting legacy in the field through groundbreaking discoveries and transformative contributions. His multidisciplinary approach, coupled with his passion for scientific inquiry, positions him as a promising leader in cancer research with the potential to drive positive change in the global fight against cancer.

Notable Publications

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on 20/04/202420/04/2024 by Book of Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Scopus

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa embarked on his academic journey with a Bachelor of Technology in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He further pursued a Master of Science in Biosciences at COMSATS University Islamabad, Pakistan, and is currently pursuing a PhD in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDS, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

With a robust academic background, Mr. Nandwa engaged in various research experiences, including his role as a Graduate Student/Research Student at the Cancer Genetics and Epigenetics Lab, COMSATS University, Pakistan. He also served as a Laboratory Analyst during his BTech internship at the Regional Veterinary Investigation Laboratory, Kenya.

Contributions and Research Focus

Mr. Nandwa's research interests span non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker/therapeutic discovery, DNA repair mechanisms, and biological data analysis. He has authored several publications and presented his research at esteemed conferences globally.

Accolades and Recognition

His notable publications include research on miRNA-4716–3p and its association with blood cancer pathogenesis, earning recognition in Non-Coding RNA Research. He has also received awards such as the Queen Elizabeth Commonwealth Scholarship and First Class Honors in BTech Industrial Microbiology and Biotechnology.

Impact and Influence

Mr. Nandwa's contributions extend beyond academia, with leadership roles in cancer education initiatives and community service engagements. His research and volunteer efforts demonstrate a commitment to advancing scientific knowledge and addressing societal challenges.

Legacy and Future Contributions

As Mr. Nandwa continues his doctoral studies and research pursuits, his dedication to understanding the intricacies of cancer biology and contributing to innovative solutions positions him as a promising researcher in the field of genetics. His leadership, academic achievements, and community impact foreshadow a legacy of scientific excellence and social responsibility.

Notable Publications

In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis 2024

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023

Jiatong Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on 23/02/202423/02/2024 by Book of Award

Assist Prof Dr. Jiatong Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Shanghai Jiao Tong University School of Medicine | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jiatong Li began her academic journey with a BA in Clinical Pharmacology at Harbin Medical University, followed by a PhD in Pharmacology under the mentorship of Prof. Bao-Feng Yang. She further honed her skills through an exchange program in Cellular Physiology at Okayama University, Japan.

Professional Endeavors

Joining Shanghai Jiao Tong University School of Medicine, Dr. Li delved into research focusing on novel antitumor therapeutics. She explored pharmacodynamics, drug actions, and underlying mechanisms, contributing significantly to the field.

Contributions and Research Focus

Dr. Li's research primarily revolves around synthesizing and applying six-membered aromatic nitrogen heterocyclic anti-tumor agents. She also investigated the suppression of hepatocellular carcinoma metastasis and cancer stem cell-like properties. Additionally, her work includes solvent-free and catalyst-free direct alkylation of alkenes.

Accolades and Recognition

Dr. Li's impactful research has earned her recognition in prestigious journals, with several publications featuring as cover stories. Her contributions have significantly advanced understanding in the field of pharmacology.

Impact and Influence

Through her research, Dr. Li has made a profound impact on the pharmacological community, shedding light on innovative therapeutic approaches and mechanisms underlying cancer progression.

Legacy and Future Contributions

Dr. Li's legacy lies in her groundbreaking research, which has paved the way for further advancements in antitumor therapeutics. Her future contributions are anticipated to continue shaping the landscape of pharmacology, with a focus on addressing critical challenges in cancer treatment.

Notable Publications

Pancreatic cancer environment: From patient-derived models to single-cell omics 2024

Six-Membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications 2023

Aggregation-enabled alkene insertion into carbon–halogen bonds 2023 (1)

Solvent-free and catalyst-free direct alkylation of alkenes 2023 (1)

Trisubstituted alkenes featuring aryl groups: stereoselective synthetic strategies and applications 2023 (3)

Nina Tuncel | Health Professions | Women Research Award

Posted on 07/02/202407/02/2024 by Book of Award

Assoc Prof Dr. Nina Tuncel | Health Professions | Women Research Award

Akdeniz University | Turkey

Author Profile

Scopus

Early Academic Pursuits

Assoc. Prof. Nina Tunçel began her academic journey with a solid foundation in physics at Al-Zahra University, Iran, where she completed her undergraduate studies from 1979 to 1987. She pursued postgraduate studies in Tıbbi Radyofizik at Istanbul University's Health Sciences Institute from 1988 to 1991, followed by a doctoral degree in the same field from 1991 to 1998. Her academic pursuits in physics laid the groundwork for her interdisciplinary research focus encompassing medicine, health sciences, and biophysics.

Professional Endeavors

Throughout her career, Assoc. Prof. Nina Tunçel has held various academic and professional positions, demonstrating her commitment to advancing knowledge and expertise in her field. She began as a Research Assistant at Istanbul University's Onkoloji Enstitüsü (Oncology Institute) from 1993 to 1996, marking the beginning of her involvement in medical physics research. Subsequently, she held positions as an Expert at Akdeniz University's Faculty of Medicine and Dokuz Eylul University's Tıp Fakültesi (Faculty of Medicine) , where she contributed significantly to radiation oncology and internal medicine.

Contributions and Research Focus

Assoc. Prof. Tunçel's research areas span a wide range of disciplines, including medicine, health sciences, internal medicine sciences, radiation oncology, physics, and interdisciplinary physics. Her expertise in biophysics and medical physics has led to numerous contributions in the understanding and application of radiation in healthcare, such as the design of tissue-mimicking gel phantoms for diffusion kurtosis imaging and the optimization of radiotherapy techniques for various cancer treatments. Her research has been published in prestigious journals indexed by SCI, SSCI, and AHCI, highlighting her significant contributions to the scientific community.

Accolades and Recognition

Assoc. Prof. Nina Tunçel has received recognition for her outstanding contributions to the field of medical physics. Her research has earned her accolades such as the Best Researcher Award, demonstrating the impact of her work on advancing knowledge and innovation in healthcare. Additionally, she has been acknowledged for her academic excellence through publications in renowned journals and presentations at international conferences, further solidifying her reputation as a leading expert in her field.

Impact and Influence

Assoc. Prof. Tunçel's work has had a profound impact on the field of medical physics, particularly in the areas of radiation oncology and biophysics. Her research has contributed to the development of innovative techniques and methodologies for cancer treatment, improving the effectiveness and precision of radiation therapy while minimizing adverse effects on patients. Through her academic endeavors and professional contributions, she has inspired future generations of scientists and clinicians to explore new frontiers in medical physics and contribute to the advancement of healthcare.

Legacy and Future Contributions

Assoc. Prof. Nina Tunçel's legacy lies in her significant contributions to the field of medical physics, which have paved the way for advancements in cancer treatment and radiation therapy. Her research has provided invaluable insights into the complex interactions between radiation and biological systems, leading to improved patient outcomes and quality of life. As she continues her academic journey, Assoc. Prof. Tunçel remains committed to pushing the boundaries of knowledge in medical physics and shaping the future of healthcare through her innovative research and dedication to excellence.

Notable Publications

Physical and chemical properties of beads glasses 2023

Radio-sensitivity on MCF-7 cells of silver nanoparticles synthesized by Silybum marianum 2023 (3)

Hybrid Tomo-Helical and Tomo-Direct radiotherapy for localized prostate cancer 2021 (1)

The dose rate measurements of C-arm fluoroscopic x-ray systems with and without apron 2018 (1)

Design and Characterisation of Tissue-Mimicking Gel Phantoms for Diffusion Kurtosis Imaging 2018 (17)